FDA Panel To Further Examine Amgen Cholesterol Drug
The U.S. Food and Drug Administration on Monday said that Amgen Inc.'s experimental drug Repatha significantly lowered bad cholesterol levels, but regulators still have questions over which patients should take the...To view the full article, register now.
Already a subscriber? Click here to view full article